CA2265198A1 - Methode d'obtention d'un medicament a base de nicotine et le medicament obtenu par cette methode - Google Patents
Methode d'obtention d'un medicament a base de nicotine et le medicament obtenu par cette methode Download PDFInfo
- Publication number
- CA2265198A1 CA2265198A1 CA002265198A CA2265198A CA2265198A1 CA 2265198 A1 CA2265198 A1 CA 2265198A1 CA 002265198 A CA002265198 A CA 002265198A CA 2265198 A CA2265198 A CA 2265198A CA 2265198 A1 CA2265198 A1 CA 2265198A1
- Authority
- CA
- Canada
- Prior art keywords
- nicotine
- medicament
- producing
- flowable mixture
- produce
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 6
- 229960002715 nicotine Drugs 0.000 title abstract 6
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 6
- 239000003814 drug Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 abstract 4
- 230000009969 flowable effect Effects 0.000 abstract 2
- 241000208125 Nicotiana Species 0.000 abstract 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract 1
- 239000011246 composite particle Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Addiction (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002265198A CA2265198C (fr) | 1998-03-11 | 1999-03-10 | Methode d'obtention d'un medicament a base de nicotine et le medicament obtenu par cette methode |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002231968A CA2231968A1 (fr) | 1998-03-11 | 1998-03-11 | Methode de production d'un medicament a base de nicotine |
| CA2,231,968 | 1998-03-11 | ||
| CA002265198A CA2265198C (fr) | 1998-03-11 | 1999-03-10 | Methode d'obtention d'un medicament a base de nicotine et le medicament obtenu par cette methode |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2265198A1 true CA2265198A1 (fr) | 1999-09-11 |
| CA2265198C CA2265198C (fr) | 2009-01-27 |
Family
ID=29712972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002265198A Expired - Lifetime CA2265198C (fr) | 1998-03-11 | 1999-03-10 | Methode d'obtention d'un medicament a base de nicotine et le medicament obtenu par cette methode |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2265198C (fr) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9585835B1 (en) | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
| US9968125B2 (en) | 2015-01-09 | 2018-05-15 | Philip Morris Products S.A. | Nicotine—diketopiperazine microparticle formulations and methods of making the same |
| US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
| US11224594B2 (en) | 2015-09-16 | 2022-01-18 | Philip Morris Products S.A. | Nicotine formulations and methods of making and using the same |
| US11707432B2 (en) | 2015-09-16 | 2023-07-25 | Philip Morris Products S.A. | System and method for controlling the harshness of nicotine-based dry powder formulations |
| WO2023187393A1 (fr) | 2022-03-31 | 2023-10-05 | Hovione Scientia Limited | Combinaison de formulation à base de support et de composite d'inhalation |
| CN117256920A (zh) * | 2023-09-27 | 2023-12-22 | 东莞市吉纯生物技术有限公司 | 一种固体雾化物及其制备方法 |
-
1999
- 1999-03-10 CA CA002265198A patent/CA2265198C/fr not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9968125B2 (en) | 2015-01-09 | 2018-05-15 | Philip Morris Products S.A. | Nicotine—diketopiperazine microparticle formulations and methods of making the same |
| US9585835B1 (en) | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
| US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
| US10660883B2 (en) | 2015-09-16 | 2020-05-26 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
| US11224594B2 (en) | 2015-09-16 | 2022-01-18 | Philip Morris Products S.A. | Nicotine formulations and methods of making and using the same |
| US11707432B2 (en) | 2015-09-16 | 2023-07-25 | Philip Morris Products S.A. | System and method for controlling the harshness of nicotine-based dry powder formulations |
| WO2023187393A1 (fr) | 2022-03-31 | 2023-10-05 | Hovione Scientia Limited | Combinaison de formulation à base de support et de composite d'inhalation |
| CN117256920A (zh) * | 2023-09-27 | 2023-12-22 | 东莞市吉纯生物技术有限公司 | 一种固体雾化物及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2265198C (fr) | 2009-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE281828T1 (de) | Nikotininhalator | |
| EP0831777B1 (fr) | Dinucleotides utiles dans le traitement de maladies pulmonaires | |
| EP1617823B1 (fr) | Sachet contenant une composition de nicotine pour administration par voie transmuqueuse | |
| CA2146954A1 (fr) | Inhalateur active par la respiration | |
| IS1768B (is) | Lyfjablanda til innöndunar sem inniheldur insúlín | |
| CA2277913A1 (fr) | Nouvelle formulation pour inhalation ayant une masse volumique apparente de 0,28 a 0,38 g/ml, procede de preparation et utilisation de cette formulation | |
| EE04628B1 (et) | Perforeeritud mikrostruktuure sisaldav pulber ja meetod perforeeritud mikrostruktuure sisaldava mikroosakeste kompositsiooni ning pulbri valmistamiseks | |
| KR970704422A (ko) | 투여용 약제학적 조성물 | |
| CA2322045A1 (fr) | Administration d'agents actifs sous forme d'aerosol | |
| CA2240717A1 (fr) | Methode de diagnostic et de traitement des troubles de la respiration pendant le sommeil et dispositif de mise en oeuvre de cette methode | |
| JP2001527442A (ja) | ハロセラピーの投与方法 | |
| CA2354576A1 (fr) | Preparation pharmaceutique pour inhalation d'un opioide | |
| CA2265198A1 (fr) | Methode d'obtention d'un medicament a base de nicotine et le medicament obtenu par cette methode | |
| EP0741588B1 (fr) | Procede de production d'un aerosol | |
| Groth et al. | Optimal inhalation procedure for the fenoterol powder inhaler | |
| AU703023B2 (en) | Dry powder delivery system | |
| CN1129088A (zh) | 香烟代用品及其使用方法 | |
| JP2002161030A (ja) | 異なる粒径をもった混合粉体の吸入方法 | |
| CN1140062A (zh) | 戒烟穴贴膏 | |
| HK59989A (en) | Improvements in or relating to nasal pharmaceutical compositions | |
| Sharpe et al. | The effects of capsaicin treatment on self-administration of amphetamine vapor in rats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20190311 |